Venous thromboembolism is one of the most common causes of morbidity and mortality in modern societies. The entirety of events involved in venous thrombus formation and resolution remains to be elucidated. Temporal relation between the initial cellular insult, thrombus formation and resolution is critical for instituting a prompt treatment. This paper analyses the current basic knowledge and the events involved in venous remodelling after an episode of venous thrombosis.
von BruhlML, StarkK, SteinhartA. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med2012; 209: 819–35
2.
HenkePK, VarmaMR, DeatrickKB. Neutrophils modulate post-thrombotic vein wall remodeling but not thrombus neovascularization.Thromb Haemost2006; 95: 272–81
BaldwinJF, SoodV, ElflineMA. The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis.J Vasc Surg2012; 56: 1089–97
5.
HenkePK, MitsuyaM, LukeCE. Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution.Arterioscler Thromb Vasc Biol2011; 31: 43–9
6.
RamacciottiE, HawleyAE, FarrisDM. Leukocyte-and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis.Thromb Hemost2009; 101: 748–54
7.
YeR, YeC, HuangY, LiuL, WangS. Circulating tissue factor positive microparticles in patients with acute recurrent deep venous thrombosis.Thromb Res2012; 130: 253–8
8.
MyersDD, HawleyAE, FarrisDM. P-selectin and leukocyte microparticles are associated with venous thrombogenesis.J Vasc Surg2003; 38: 1075–89
9.
MyersDDJr, RectenwaldJE, BedardPW. Decreased venous thrombosis with an oral inhibitor of P selectin.J Vasc Surg2005; 42: 329–36
10.
van RamshorstB, van BemmelenPS, HoeneveldH, FaberJA, EikelboomBC. Thrombus regression in deep venous thrombosis. Quantification of spontaneous thrombolysis with duplex scanning.Circulation1992; 86: 414–9
11.
AkessonH, BrudinL, DahlstromJA, EklofB, OhlinP, PlateG. Venous function assessed during a 5 year period after acute iliofemoral venous thrombosis treated with anticoagulation.Eur J Vasc Surg1990; 4: 43–8
12.
LabropoulosN, GasparisAP, TassiopoulosAK. Prospective evaluation of the clinical deterioration in post-thrombotic limbs.J Vasc Surg2009; 50: 826–30
13.
YamakiT, NozakiM. Patterns of venous insufficiency after an acute deep vein thrombosis.J Am Coll Surg2005; 201: 231–8
LabropoulosN, WaggonerT, SammisW, SamaliS, PappasPJ. The effect of venous thrombus location and extent on the development of post-thrombotic signs and symptoms.J Vasc Surg2008; 48: 407–12
ThomasML, McAllisterV. The radiological progression of deep venous thrombus.Radiology1971; 99: 37–40
18.
TickLW, KramerMH, RosendaalFR, FaberWR, DoggenCJ. Risk factors for post-thrombotic syndrome in patients with a first deep venous thrombosis.J Thromb Haemost2008; 6: 2075–81
19.
KahnSR, ShrierI, JulianJA. Determinants and time course of the post-thrombotic syndrome after acute deep venous thrombosis.Ann Intern Med2008; 149: 698–707
20.
StainM, SchonauerV, MinarE. The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease.J Thromb Haemost2005; 3: 2671–6
21.
LabropoulosN, KangSS, MansourMA, GiannoukasAD, MoutzourosV, BakerWH. Early thrombus remodeling of isolated calf deep vein thrombosis.Eur J Vasc Endovasc Surg2002; 23: 344–8
22.
KahnSR, ShbakloH, LampingDL. Determinants of health-related quality of life during the 2 years following deep vein thrombosis.J Thromb Haemost2008; 6: 1105–2
23.
HullRD, LiangJ, TownshendG. Long-term low-molecular-weight heparin and the post-thrombotic syndrome: a systematic review.Am J Med2011; 124: 756–65
24.
ElsharawyM, ElzayatE. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomised clinical trial.Eur J Vasc Endovasc Surg2002; 24: 209–14
25.
EndenT, KlowNE, SandvikL. Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency.J Thromb Haemost2009; 7: 1268–75
26.
BushRL, LinPH, BatesJT, MureebeL, ZhouW, LumsdenAB. Pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis: safety and feasibility study.J Vasc Surg2004; 40: 965–70
27.
GasparisAP, LabropoulosN, TassiopoulosAK. Midterm follow-up after pharmacomechanical thrombolysis for lower extremity deep venous thrombosis.Vasc Endovasc Surg2009; 43: 61–8
28.
MalgorRD, GasparisAP. pharmacomechanical thrombectomy for early thrombus removal.Phlebology2012; 27 (Suppl. 1): 155–62
